Cancer Research Cancer Research Funding Available  Sign up for Cancer Research eTOC's
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online

[Cancer Research 36, 2512-2517, July 1, 1976]
© 1976 American Association for Cancer Research

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Jacobs, J. B.
Right arrow Articles by Friedell, G. H.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Jacobs, J. B.
Right arrow Articles by Friedell, G. H.

Early Lesions in Experimental Bladder Cancer: Scanning Electron Microscopy of Cell Surface Markers1

Jerome B. Jacobs2, Masayuki Arai, Samuel M. Cohen and Gilbert H. Friedell

Department of Pathology, St. Vincent Hospital, Worcester 01604, and Department of Pathology, University of Massachusetts Medical School, Worcester, Massachusetts 01605

The administration of N-[4-(5-nitro-2-furyl)-2-thiazolyl]formamide (FANFT) at a dose of 0.2% of the diet to male Fischer rats results in the appearance of urinary bladder epithelial lesions progressing from hyperplasia to invasive transitional cell carcinomas. These progressive epithelial alterations have been observed by scanning electron microscopy at 2-week intervals with special attention paid to cells covering the luminal surface. After 2 to 4 weeks of FANFT administration there is mild pleomorphism and moderate swelling of the surface cells giving a cobblestone appearance. The normal pattern of microridges of superficial transitional cells is still present, although occasional cells by 4 weeks of FANFT feeding are covered by small uniform microvilli. By 6 weeks these changes are more extensive and more cells are covered with uniform microvilli. By 8 weeks, cells covered with pleomorphic microvilli are found in discrete foci, and by 10 weeks nodular or papillary lesions are present. The 2- and 4-week lesions regress to normal within 2 to 4 weeks of discontinuing FANFT administration, and the 6- and 8-week lesions regress toward normal in 4 to 6 weeks of being fed control diet. The 6-week lesions have regressed entirely to normal 44 weeks after FANFT was stopped, but the 8-week lesions have progressed to moderate or marked hyperplastic lesions by 42 weeks of control diet with pleomorphic cells covered with pleomorphic microvilli. The results of this study suggest that lesions are reversible up to and including 6 weeks of 0.2% FANFT in the diet, and that, by 8 weeks of 0.2% FANFT, irreversible lesions result which do not revert to normal after 42 weeks of control diet.

1 Presented at the Conference "Early Lesions and the Development of Epithelial Cancer," October 21 to 23, 1975, Bethesda, Md. This study was supported in part by USPHS Grant CA-15945 from the National Cancer Institute through the National Bladder Cancer Project.

2 Presenter.




This article has been cited by other articles:


Home page
Am. J. Physiol. Renal Physiol.Home page
P. Hu, S. Meyers, F.-X. Liang, F.-M. Deng, B. Kachar, M. L. Zeidel, and T.-T. Sun
Role of membrane proteins in permeability barrier function: uroplakin ablation elevates urothelial permeability
Am J Physiol Renal Physiol, December 1, 2002; 283(6): F1200 - F1207.
[Abstract] [Full Text] [PDF]


Home page
Vet PatholHome page
V. Ambrosio, G. Borzacchiello, F. Bruno, P. Galati, and F. Roperto
Uroplakin Expression in the Urothelial Tumors of Cows
Vet. Pathol., November 1, 2001; 38(6): 657 - 660.
[Abstract] [Full Text] [PDF]


Home page
Toxicol PatholHome page
K. Ogawa, M. St. John, M. L. De Oliveira, L. Arnold, T. Shirai, T.-T. Sun, and S. M. Cohen
Comparison of Uroplakin Expression During Urothelial Carcinogenesis Induced by N-Butyl-N-(4-Hydroxybutyl)Nitrosamine in Rats and Mice
Toxicol Pathol, November 1, 1999; 27(6): 645 - 651.
[Abstract] [PDF]


Home page
Toxicol PatholHome page
H. Iwata, S. Yamamoto, Y. Yano, S. Ohtani, and S. Fukushima
Dose-Dependent Amplification by L-Ascorbic Acid of NaHCO3 Promotion of Rat Urinary Bladder Carcinogenesis
Toxicol Pathol, May 1, 1997; 25(3): 284 - 290.
[Abstract] [PDF]


Home page
Toxicol PatholHome page
S. Molon-Noblot, C. Boussiquet-Leroux, R. A. Owen, E. Irisarri, G. Durand-Cavagna, C. P. Peter, and P. Duprat
Rat Urinary Bladder Hyperplasia Induced by Oral Administration of Carbonic Anhydrase Inhibitors
Toxicol Pathol, January 1, 1992; 20(1): 93 - 102.
[Abstract] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online
Copyright © 1976 by the American Association for Cancer Research.